| The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy. | |
| | |
MedLine Citation:
|
PMID: 16144734 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There is not only a need for scientific data regarding the risk of recurrence of breast cancer by starting hormone replacement therapy (HRT) but also regarding the patients' needs for HRT. OBJECTIVES: To examine the severity of climacteric complaints in breast cancer patients and to examine if they are willing to take HRT. METHODS: In November 2003, a questionnaire was sent to 469 breast cancer survivors. The survey examined on a scale base the severity of climacteric complaints and the patient's opinion on starting HRT. RESULTS: More than 76% of the patients complained that they experience or had experienced hot flushes or night sweating. More than half (53%) of this group found the inconvenience severe to extreme, affecting the patient's quality of life. A majority (80.5%) patients who had already taken HRT, found that it improved their quality of life substantially. When the results of observational studies were explained regarding HRT in breast cancer survivors, a majority said they would take or would consider taking HRT (57.9%). CONCLUSION: While physicians are more reserved in prescribing HRT in breast cancer survivors, a combination of severe symptomatic climacteric complaints and the willingness of the patient to be treated should at least result in a "consideration" of prescribing HRT. |
| | |
Authors:
|
Xuan-Bich Trinh; Frederik Peeters; Wiebren A A Tjalma |
Related Documents
:
|
22976924 - Prostate epithelial ar inactivation leads to increased intraprostatic androgen synthesis. 16670704 - Baseline psychosocial predictors of survival in localised breast cancer. 10373814 - A study of postdiagnosis breast cancer concerns for women living in rural and remote qu... 23104394 - Can t2-weighted 3-t breast mri predict clinically occult inflammatory breast cancer bef... 9646234 - Histopathological study of 110 cystectomy specimens for bladder cancer by an original m... 719614 - Variables predictive of bone marrow metastasis. |
Publication Detail:
|
Type: Journal Article Date: 2005-09-06 |
Journal Detail:
|
Title: European journal of obstetrics, gynecology, and reproductive biology Volume: 124 ISSN: 0301-2115 ISO Abbreviation: Eur. J. Obstet. Gynecol. Reprod. Biol. Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-01-27 Completed Date: 2007-08-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375672 Medline TA: Eur J Obstet Gynecol Reprod Biol Country: Ireland |
Other Details:
|
Languages: eng Pagination: 250-3 Citation Subset: IM |
Affiliation:
|
Department of Gynaecology and Gynaecologic Oncology, University Hospital Antwerp, Edegem, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Attitude to Health* Breast Neoplasms / psychology* Data Collection Estrogens / adverse effects, therapeutic use Female Hormone Replacement Therapy / adverse effects, psychology* Hot Flashes / drug therapy* Humans Middle Aged Neoplasm Recurrence, Local / chemically induced Postmenopause Progesterone / adverse effects, therapeutic use Quality of Life Questionnaires Risk Factors Survivors / psychology* |
| Chemical | |
Reg. No./Substance:
|
0/Estrogens; 57-83-0/Progesterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluating the role of desorption in bioavailability of sediment-associated contaminants using oligo...
Next Document: Quaternized agricultural by-products as anion exchange resins.